PhotoPharmics
Salt Lake City, United States· Est. 2009
Over 11 million people worldwide live with Parkinson’s disease (PD), a number that is projected to double over the next 20 years. As with so many other neurodegenerative diseases, there have been no major breakthroughs in Parkinson’s disease in decades.
Private Company
Total funding raised: $12.5M
About
Over 11 million people worldwide live with Parkinson’s disease (PD), a number that is projected to double over the next 20 years. As with so many other neurodegenerative diseases, there have been no major breakthroughs in Parkinson’s disease in decades.
OphthalmologyNeuroscience
Funding History
2Total raised:$12.5M
Series A$10MSep 15, 2022
Seed$2.5MJun 15, 2021